FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
219070NDACRINETICS PHARMA INC001PALSONIFYTABLET;ORAL20MGPALTUSOTINE2025-09-25PrescriptionNo
002PALSONIFYTABLET;ORAL30MGPALTUSOTINE2025-09-25PrescriptionNo